{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T08:27:46Z","timestamp":1793262466819,"version":"4.5.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2022MH284"],"award-info":[{"award-number":["ZR2022MH284"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Natriuretic peptide receptor 2 (\n                      <jats:italic>NPR2<\/jats:italic>\n                      ) is a crucial regulator of endochondral bone growth. However, patients carrying heterozygous\n                      <jats:italic>NPR2<\/jats:italic>\n                      gene mutations exhibit a wide range of clinical phenotypes, and evidence regarding treatment efficacy is limited, with the pathogenic mechanisms not yet fully understood. Therefore, the aim of this study is to analyze and identify the clinical phenotypes, treatment outcomes, and pathogenic molecular mechanisms associated with\n                      <jats:italic>NPR2<\/jats:italic>\n                      gene mutations.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Through exome sequencing, we sequenced\n                      <jats:italic>NPR2<\/jats:italic>\n                      in three Chinese Han patients with short stature and validated the results in their families. Clinical characteristics, treatment follow-up analysis, protein 3D structure prediction, in vitro functional experiments, and transcriptome sequencing were used to examine the protein changes caused by the variants, their pathogenicity, and the underlying molecular mechanisms of the disease.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      All three patients with\n                      <jats:italic>NPR2<\/jats:italic>\n                      (p.R318W, p.I908T, p.R976H) gene mutations exhibited non-specific skeletal dysplasia and short stature, with good efficacy of recombinant human growth hormone (rhGH) treatment. Compared to the wild type, the protein expression level of\n                      <jats:italic>NPR2<\/jats:italic>\n                      mutants was significantly reduced (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001), and CNP-induced cyclic guanosine monophosphate (cGMP) production was significantly decreased (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.0001). Transcriptome sequencing analysis revealed that\n                      <jats:italic>Csf2<\/jats:italic>\n                      is a key differentially expressed gene between\n                      <jats:italic>NPR2<\/jats:italic>\n                      mutant and wild type, and also an upstream regulator of the JAK2-STAT5 pathway. Further validation via qRT-PCR and Western blot showed that\n                      <jats:italic>NPR2<\/jats:italic>\n                      gene mutations significantly reduced\n                      <jats:italic>Csf2<\/jats:italic>\n                      gene mRNA expression (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.05), and protein expression of JAK2, p-JAK2, and p-STAT5 was significantly decreased (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.05). Further analysis revealed that\n                      <jats:italic>NPR2<\/jats:italic>\n                      gene mutations significantly affected the expression of chondrocyte differentiation markers\n                      <jats:italic>Sox9<\/jats:italic>\n                      ,\n                      <jats:italic>Col2A1<\/jats:italic>\n                      , and\n                      <jats:italic>BMP4<\/jats:italic>\n                      (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      Our study provides new insights into the loss of function of\n                      <jats:italic>NPR2<\/jats:italic>\n                      .\n                      <jats:italic>NPR2<\/jats:italic>\n                      gene mutations may influence the expression and phosphorylation levels of proteins in the JAK2-STAT5 signaling pathway by downregulating\n                      <jats:italic>Csf2<\/jats:italic>\n                      , thereby affecting chondrocyte differentiation and ultimately leading to short stature.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13023-025-03936-5","type":"journal-article","created":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T05:26:41Z","timestamp":1754026001000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Identification of NPR2 gene mutations affecting chondrocyte differentiation in short stature through JAK2-STAT5"],"prefix":"10.1186","volume":"20","author":[{"given":"Shuoshuo","family":"Wei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingming","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuanpeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanying","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinguo","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Ban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianqian","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,1]]},"reference":[{"key":"3936_CR1","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1038\/s41586-019-0874-3","volume":"565","author":"S Stegen","year":"2019","unstructured":"Stegen S, Laperre K, Eelen G, Rinaldi G, Fraisl P, Torrekens S, et al. HIF-1\u03b1 metabolically controls collagen synthesis and modification in chondrocytes. Nature. 2019;565:511\u20135.","journal-title":"Nature"},{"key":"3936_CR2","doi-asserted-by":"publisher","first-page":"6009","DOI":"10.3390\/ijms20236009","volume":"20","author":"SA Hallett","year":"2019","unstructured":"Hallett SA, Ono W, Ono N. Growth plate chondrocytes: skeletal development, growth and beyond. Int J Mol Sci. 2019;20:6009.","journal-title":"Int J Mol Sci"},{"key":"3936_CR3","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.ymgme.2007.06.014","volume":"92","author":"K Pejchalova","year":"2007","unstructured":"Pejchalova K, Krejci P, Wilcox WR. C-natriuretic peptide: an important regulator of cartilage. Mol Genet Metab. 2007;92:210\u20135.","journal-title":"Mol Genet Metab"},{"key":"3936_CR4","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1210\/er.2005-0014","volume":"27","author":"LR Potter","year":"2006","unstructured":"Potter LR, Abbey-Hosch S, Dickey DM. Natriuretic peptides, their receptors, and cyclic guanosine monophosphate-dependent signaling functions. Endocr Rev. 2006;27:47\u201372.","journal-title":"Endocr Rev"},{"key":"3936_CR5","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1007\/s12020-020-02362-w","volume":"71","author":"MF Faienza","year":"2021","unstructured":"Faienza MF, Chiarito M, Brunetti G, D\u2019Amato G. Growth plate gene involment and isolated short stature. Endocrine. 2021;71:28\u201334.","journal-title":"Endocrine"},{"key":"3936_CR6","doi-asserted-by":"publisher","first-page":"5089","DOI":"10.1242\/jcs.02618","volume":"118","author":"P Krejci","year":"2005","unstructured":"Krejci P, Masri B, Fontaine V, Mekikian PB, Weis M, Prats H, et al. Interaction of fibroblast growth factor and C-natriuretic peptide signaling in regulation of chondrocyte proliferation and extracellular matrix homeostasis. J Cell Sci. 2005;118:5089\u2013100.","journal-title":"J Cell Sci"},{"key":"3936_CR7","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1016\/j.joca.2014.07.018","volume":"22","author":"NJ Peake","year":"2014","unstructured":"Peake NJ, Hobbs AJ, Pingguan-Murphy B, Salter DM, Berenbaum F, Chowdhury TT. Role of C-type natriuretic peptide signalling in maintaining cartilage and bone function. Osteoarthr Cartil. 2014;22:1800\u20137.","journal-title":"Osteoarthr Cartil"},{"key":"3936_CR8","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.3390\/genes13061065","volume":"13","author":"L Stavber","year":"2022","unstructured":"Stavber L, Gaia MJ, Hovnik T, Jenko Bizjan B, Debeljak M, Kova\u010d J, et al. Heterozygous NPR2 variants in idiopathic short stature. Genes (Basel). 2022;13:1065.","journal-title":"Genes (Basel)"},{"key":"3936_CR9","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1210\/clinem\/dgaa842","volume":"106","author":"X Ke","year":"2021","unstructured":"Ke X, Liang H, Miao H, Yang H, Wang L, Gong F, et al. Clinical characteristics of short-stature patients with an NPR2 mutation and the therapeutic response to rhGH. J Clin Endocrinol Metab. 2021;106:431\u201341.","journal-title":"J Clin Endocrinol Metab"},{"key":"3936_CR10","doi-asserted-by":"publisher","first-page":"e1146","DOI":"10.1002\/mgg3.1146","volume":"8","author":"IT Hwang","year":"2020","unstructured":"Hwang IT, Mizuno Y, Amano N, Lee HJ, Shim YS, Nam HK, et al. Role of NPR2 mutation in idiopathic short stature: identification of two novel mutations. Mol Genet Genom Med. 2020;8:e1146.","journal-title":"Mol Genet Genom Med"},{"key":"3936_CR11","doi-asserted-by":"publisher","first-page":"E713","DOI":"10.1210\/jc.2013-3525","volume":"99","author":"N Amano","year":"2014","unstructured":"Amano N, Mukai T, Ito Y, Narumi S, Tanaka T, Yokoya S, et al. Identification and functional characterization of two novel NPR2 mutations in Japanese patients with short stature. J Clin Endocrinol Metab. 2014;99:E713\u20138.","journal-title":"J Clin Endocrinol Metab"},{"key":"3936_CR12","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.3390\/cells11081265","volume":"11","author":"Q Li","year":"2022","unstructured":"Li Q, Fan X, Lu W, Sun C, Pei Z, Zhang M, et al. Novel NPR2 gene mutations affect chondrocytes function via ER stress in short stature. Cells. 2022;11:1265.","journal-title":"Cells"},{"key":"3936_CR13","first-page":"487","volume":"47","author":"H Li","year":"2009","unstructured":"Li H, Ji CY, Zong XN, Zhang YQ. Height and weight standardized growth charts for Chinese children and adolescents aged 0 to 18 years. Chin J Pediatr. 2009;47:487\u201392.","journal-title":"Chin J Pediatr"},{"key":"3936_CR14","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/j.eprac.2022.04.004","volume":"28","author":"B Cao","year":"2022","unstructured":"Cao B, Peng Y, Song W, Peng X, Hu L, Liu Z, et al. Pediatric continuous reference intervals of serum insulin-like growth factor 1 levels in a healthy Chinese children population\u2014based on PRINCE study. Endocr Pract. 2022;28:696\u2013702.","journal-title":"Endocr Pract"},{"key":"3936_CR15","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1007\/s00256-017-2867-3","volume":"47","author":"A Hojreh","year":"2018","unstructured":"Hojreh A, Gamper J, Schmook MT, Weber M, Prayer D, Herold CJ, et al. Hand MRI and the Greulich-Pyle atlas in skeletal age estimation in adolescents. Skelet Radiol. 2018;47:963\u201371.","journal-title":"Skelet Radiol"},{"key":"3936_CR16","doi-asserted-by":"publisher","first-page":"117779","DOI":"10.1016\/j.cca.2024.117779","volume":"554","author":"Q Zhao","year":"2024","unstructured":"Zhao Q, Zhang M, Li Y, Zhang C, Zhang Y, Shao Q, et al. Molecular diagnosis is an important indicator for response to growth hormone therapy in children with short stature. Clin Chim Acta. 2024;554:117779.","journal-title":"Clin Chim Acta"},{"key":"3936_CR17","doi-asserted-by":"publisher","first-page":"e31343","DOI":"10.7554\/eLife.31343","volume":"6","author":"LC Shuhaibar","year":"2017","unstructured":"Shuhaibar LC, Robinson JW, Vigone G, Shuhaibar NP, Egbert JR, Baena V, et al. Dephosphorylation of the NPR2 guanylyl cyclase contributes to inhibition of bone growth by fibroblast growth factor. Elife. 2017;6:e31343.","journal-title":"Elife"},{"key":"3936_CR18","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/gim.2017.66","volume":"20","author":"A Hisado-Oliva","year":"2018","unstructured":"Hisado-Oliva A, Ruzafa-Martin A, Sentchordi L, Funari MFA, Bezanilla-L\u00f3pez C, Alonso-Bern\u00e1ldez M, et al. Mutations in C-natriuretic peptide (NPPC): a novel cause of autosomal dominant short stature. Genet Med. 2018;20:91\u20137.","journal-title":"Genet Med"},{"key":"3936_CR19","first-page":"7658496","volume":"2018","author":"M Jacob","year":"2018","unstructured":"Jacob M, Menon S, Botti C, Marshall I. Heterozygous NPR2 mutation in two family members with short stature and skeletal dysplasia. Case Rep Endocrinol. 2018;2018:7658496.","journal-title":"Case Rep Endocrinol"},{"key":"3936_CR20","doi-asserted-by":"publisher","first-page":"dgaa037","DOI":"10.1210\/clinem\/dgaa037","volume":"105","author":"L Plachy","year":"2020","unstructured":"Plachy L, Dusatkova P, Maratova K, Petruzelkova L, Zemkova D, Elblova L, et al. NPR2 variants are frequent among children with familiar short stature and respond well to growth hormone therapy. J Clin Endocrinol Metab. 2020;105:dgaa037.","journal-title":"J Clin Endocrinol Metab"},{"key":"3936_CR21","doi-asserted-by":"publisher","first-page":"E1636","DOI":"10.1210\/jc.2013-2142","volume":"98","author":"GA Vasques","year":"2013","unstructured":"Vasques GA, Amano N, Docko AJ, Funari MF, Quedas EP, Nishi MY, et al. Heterozygous mutations in natriuretic peptide receptor-B (NPR2) gene as a cause of short stature in patients initially classified as idiopathic short stature. J Clin Endocrinol Metab. 2013;98:E1636\u201344.","journal-title":"J Clin Endocrinol Metab"},{"key":"3936_CR22","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1186\/s13023-023-02757-8","volume":"18","author":"H Chen","year":"2023","unstructured":"Chen H, Zhang S, Sun Y, Chen J, Yuan K, Zhang Y, et al. Novel pathogenic NPR2 variants in short stature patients and the therapeutic response to rhGH. Orphanet J Rare Dis. 2023;18:221.","journal-title":"Orphanet J Rare Dis"},{"key":"3936_CR23","doi-asserted-by":"publisher","first-page":"3190","DOI":"10.1210\/clinem\/dgaa491","volume":"105","author":"PC Hanley","year":"2020","unstructured":"Hanley PC, Kanwar HS, Martineau C, Levine MA. Short stature is progressive in patients with heterozygous NPR2 mutations. J Clin Endocrinol Metab. 2020;105:3190\u2013202.","journal-title":"J Clin Endocrinol Metab"},{"key":"3936_CR24","doi-asserted-by":"publisher","first-page":"E1988","DOI":"10.1210\/jc.2013-2358","volume":"98","author":"SE Hannema","year":"2013","unstructured":"Hannema SE, van Duyvenvoorde HA, Premsler T, Yang RB, Mueller TD, Gassner B, et al. An activating mutation in the kinase homology domain of the natriuretic peptide receptor-2 causes extremely tall stature without skeletal deformities. J Clin Endocrinol Metab. 2013;98:E1988\u201398.","journal-title":"J Clin Endocrinol Metab"},{"key":"3936_CR25","doi-asserted-by":"publisher","first-page":"823861","DOI":"10.3389\/fgene.2022.823861","volume":"13","author":"J Wu","year":"2022","unstructured":"Wu J, Wang M, Jiao Z, Dou B, Li B, Zhang J, et al. Novel loss-of-function mutations in NPR2 cause acromesomelic dysplasia, Maroteaux Type. Front Genet. 2022;13:823861.","journal-title":"Front Genet"},{"key":"3936_CR26","doi-asserted-by":"publisher","first-page":"e71931","DOI":"10.7554\/eLife.71931","volume":"11","author":"Y Miyazaki","year":"2022","unstructured":"Miyazaki Y, Ichimura A, Kitayama R, Okamoto N, Yasue T, Liu F, et al. C-type natriuretic peptide facilitates autonomic Ca(2+) entry in growth plate chondrocytes for stimulating bone growth. Elife. 2022;11:e71931.","journal-title":"Elife"},{"key":"3936_CR27","doi-asserted-by":"publisher","first-page":"3857","DOI":"10.1016\/j.cell.2022.09.023","volume":"185","author":"RL Philips","year":"2022","unstructured":"Philips RL, Wang Y, Cheon H, Kanno Y, Gadina M, Sartorelli V, et al. The JAK-STAT pathway at 30: much learned, much more to do. Cell. 2022;185:3857\u201376.","journal-title":"Cell"},{"key":"3936_CR28","doi-asserted-by":"publisher","first-page":"9087","DOI":"10.1007\/s11033-020-05910-9","volume":"47","author":"ER Sanpaolo","year":"2020","unstructured":"Sanpaolo ER, Rotondo C, Cici D, Corrado A, Cantatore FP. JAK\/STAT pathway and molecular mechanism in bone remodeling. Mol Biol Rep. 2020;47:9087\u201396.","journal-title":"Mol Biol Rep"},{"key":"3936_CR29","first-page":"7","volume":"43","author":"L Chen","year":"2021","unstructured":"Chen L, Zhang H, Xu X, Xu K, Zhu M. MiR-370-3P inhibits proliferation of human articular chondrocytes by regulating JAK2\/STAT5B signaling pathway. J Third Mil Med Univ. 2021;43:7.","journal-title":"J Third Mil Med Univ"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-03936-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-025-03936-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-03936-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T10:37:28Z","timestamp":1757327848000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-025-03936-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,1]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3936"],"URL":"https:\/\/doi.org\/10.1186\/s13023-025-03936-5","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,1]]},"assertion":[{"value":"16 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study received ethical approval from the Human Ethics Committee of the Affiliated Hospital of Jining Medical University. All participants or their parents provided written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"392"}}